Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb". 1990

K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
Institute for Clinical and Experimental Medicine, Prague.

A new type of styrene-divinylbenzene copolymer coated with polyhema was tested for biocompatibility and ability to remove bile acid, bilirubin, phenols and cholesterol in dogs with surgically induced biliary obstruction. After 4-hr hemoperfusion through a polypropylene column containing 325 g of resin, performed 7-10 days after the ligature of the cystic and common bile duct, the serum levels of bile acids, bilirubin, phenols and cholesterol decreased by 60.9 +/- 30.3% (p less than 0.001), 34.8 +/- 12.2% (p less than 0.001), 19.4 +/- 15.6% (p less than 0.001) and 15.3 +/- 4.2% (p less than 0.05), respectively. The procedure was well tolerated, no bleeding or other adverse reactions occurred. The average platelet count decreased by 19.4 +/- 15.6% (p less than 0.05). Hemoperfusion through the Czechoslovak resin coated with polyhema is safe and efficient for removal of bile acids and other protein-bound and lipid-soluble substances which accumulate in cholestatic syndromes and hepatic failure. Thus, it may play an important role in the treatment of such events as a method of artificial liver support.

UI MeSH Term Description Entries
D008297 Male Males
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D001651 Cholestasis, Extrahepatic Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes. Bile Duct Obstruction, Extrahepatic,Biliary Stasis, Extrahepatic,Extrahepatic Cholestasis,Extrahepatic Biliary Stasis
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
September 1975, Lancet (London, England),
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
October 1979, The Journal of laboratory and clinical medicine,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
January 1983, Nihon Geka Gakkai zasshi,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
April 1996, Journal of the Indian Medical Association,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
January 1982, Contributions to nephrology,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
September 1986, The International journal of artificial organs,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
January 1979, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
March 1973, Lancet (London, England),
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
May 1981, The International journal of artificial organs,
K Filip, and J Malý, and J Horký, and M Tlustáková, and J Kálal, and M Vrána
January 1986, ASAIO transactions,
Copied contents to your clipboard!